Back
HFA Premium Access

Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes (EBAC Accredited)

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure
Topic: Diabetes and the Heart
Session type: Satellite Symposium
Organised by the Sahlgrenska Academy, University of Gothenburg, Sweden, supported with an educational grant from AstraZeneca. Course Director: Professor Karl Swedberg
Date: 26 May 2019
Time: 12:45 - 13:45

Congress Session

0
6 presentations in this session

Welcome and introductions - Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes.

Speaker: Professor A. Mebazaa (Paris, FR)
Access
0
Thumbnail

What have cardiovascular outcomes trials taught us about cardiovascular risk management?

Speaker: Professor M. Pfeffer (Boston, US)
Access
0
Thumbnail

Emerging knowledge on cardiorenal protection.

Speaker: Professor S. Verma (Toronto, CA)
Access
0
Thumbnail

From classroom to clinic: sodium–glucose co-transporter 2 inhibitor evidence in practice.

Speaker: Professor S. Verma (Toronto, CA)
Speaker: Professor M. Cowie (London, GB)
Speaker: Doctor S. Wiviott (Boston, US)
Speaker: Professor A. Mebazaa (Paris, FR)
Access
0
Thumbnail

What we still need to learn from sodium–glucose co-transporter 2 inhibitors to predict the future.

Speaker: Professor M. Cowie (London, GB)
Access
0
Thumbnail

Q&A - Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes.

Speaker: Professor S. Verma (Toronto, CA)
Speaker: Professor M. Cowie (London, GB)
Speaker: Professor A. Mebazaa (Paris, FR)
Speaker: Professor M. Pfeffer (Boston, US)
Access
0
Thumbnail

12 speakers from this session

Professor Alexandre Mebazaa

Hospital Lariboisiere, Paris (France)
54 presentations
3 followers

Professor Marc Pfeffer

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
23 presentations
0 follower

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)
20 presentations
0 follower

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)
20 presentations
0 follower

Professor Martin Cowie

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
93 presentations
3 followers

Doctor Stephen Wiviott

Brigham and Women's Hospital, Boston (United States of America)
1 presentation
0 follower

Professor Alexandre Mebazaa

Hospital Lariboisiere, Paris (France)
54 presentations
3 followers

Professor Martin Cowie

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
93 presentations
3 followers

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)
20 presentations
0 follower

Professor Martin Cowie

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
93 presentations
3 followers

Professor Alexandre Mebazaa

Hospital Lariboisiere, Paris (France)
54 presentations
3 followers

Professor Marc Pfeffer

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
23 presentations
0 follower

This platform is supported by

logo Novo Nordisk